These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Seven-day triple therapy with ranitidine bismuth citrate or omeprazole and two antibiotics for eradication of Helicobacter pylori in duodenal ulcer: a multicentre, randomized, single-blind study. Spinzi GC; Boni F; Bortoli A; Colombo E; Ballardini G; Venturelli R; Minoli G Aliment Pharmacol Ther; 2000 Mar; 14(3):325-30. PubMed ID: 10735926 [TBL] [Abstract][Full Text] [Related]
5. Ranitidine bismuth citrate with clarithromycin versus omeprazole with amoxycillin in the cure of Helicobacter pylori infection. Kolkman JJ; Tan TG; Oudkerk Pool M; Van Kleef WA; Geraedts AA; Timmerman RJ; Crobach LF; Nicolai JJ; Wolff AA; Van Der Laan J Aliment Pharmacol Ther; 1997 Dec; 11(6):1123-9. PubMed ID: 9663840 [TBL] [Abstract][Full Text] [Related]
6. Ranitidine bismuth citrate with either clarithromycin 1 g/day or 1.5 g/day is equally effective in the eradication of H. pylori and healing of duodenal ulcer. Dobrilla G; Di Matteo G; Dodero M; Fratton A; Iaquinto G; Loriga P; Marchi S; Marzio L; Muratori R; Pacini D; Saggioro A; Savarino V; Spinelli P; Zamboni G; Fina P; Tosatto R; Olivieri A Aliment Pharmacol Ther; 1998 Jan; 12(1):63-8. PubMed ID: 9692703 [TBL] [Abstract][Full Text] [Related]
7. Ranitidine bismuth citrate plus clarithromycin is effective for healing duodenal ulcers, eradicating H. pylori and reducing ulcer recurrence. RBC H. pylori Study Group. Peterson WL; Ciociola AA; Sykes DL; McSorley DJ; Webb DD Aliment Pharmacol Ther; 1996 Jun; 10(3):251-61. PubMed ID: 8791947 [TBL] [Abstract][Full Text] [Related]
8. Randomized comparison of 1-hour topical method vs. amoxycillin plus omeprazole for eradication of Helicobacter pylori in duodenal ulcer patients. Przytulski K; Regula J; Dziurkowska-Marek A; Kohut M; Hennig E; Marek T; Ostrowski J; Nowak A; Butruk E Aliment Pharmacol Ther; 1998 Jan; 12(1):69-75. PubMed ID: 9692704 [TBL] [Abstract][Full Text] [Related]
9. Comparison of 1-week vs. 2- or 4-week therapy regimens with ranitidine bismuth citrate plus two antibiotics for Helicobacter pylori eradication. Kamberoglou D; Polymeros D; Sanidas I; Doulgeroglou V; Savva S; Patra E; Tzias V Aliment Pharmacol Ther; 2001 Sep; 15(9):1493-7. PubMed ID: 11552924 [TBL] [Abstract][Full Text] [Related]
10. Omeprazole or ranitidine bismuth citrate triple therapy to treat Helicobacter pylori infection: a randomized, controlled trial in Vietnamese patients with duodenal ulcer. Mao HV; Lak BV; Long T; Chung NQ; Thang DM; Hop TV; Chien NN; Hoan PQ; Henley KS; Perez-Perez GI; Connor BA; Stone CD; Chey WD Aliment Pharmacol Ther; 2000 Jan; 14(1):97-101. PubMed ID: 10632652 [TBL] [Abstract][Full Text] [Related]
11. [Lansoprazole versus ranitidine bismuth citrate containing triple regimens for Helicobacter pylori eradication in patients with duodenal ulcer]. Buzás György M; Székely E; Illyés G; Széles I Orv Hetil; 2000 Jul; 141(31):1711-4. PubMed ID: 10976194 [TBL] [Abstract][Full Text] [Related]
12. Ranitidine bismuth citrate-based triple therapy for seven days, with or without further anti-secretory therapy, is highly effective in patients with duodenal ulcer and Helicobacter pylori infection. Marchi S; Costa F; Bellini M; Belcari C; Mumolo MG; Tornar A; Spisni R; Torelli E; Maltinti G Eur J Gastroenterol Hepatol; 2001 May; 13(5):547-50. PubMed ID: 11396535 [TBL] [Abstract][Full Text] [Related]
13. The impact of primary antibiotic resistance on the efficacy of ranitidine bismuth citrate- vs. omeprazole-based one-week triple therapies in H. pylori eradication--a randomised controlled trial. Bago J; Halle ZB; Strinić D; Kućisec N; Jandrić D; Bevanda M; Tomić M; Bilić A Wien Klin Wochenschr; 2002 Jun; 114(12):448-53. PubMed ID: 12422579 [TBL] [Abstract][Full Text] [Related]
14. [new one-week triple therapies with metronidazole for the eradication of Helicobacter pylori: clarithromycin or amoxycillin as the second antibiotic]. Gisbert JP; Boixeda D; Martín de Argila C; Redondo C; Moreno L; Abraira V; García Plaza A Med Clin (Barc); 1998 Jan; 110(1):1-5. PubMed ID: 9527978 [TBL] [Abstract][Full Text] [Related]
15. One-week therapy for Helicobacter pylori eradication: ranitidine bismuth citrate plus medium-dose clarithromycin and either tinidazole or amoxycillin. Cammarota G; Cannizzaro O; Tursi A; Papa A; Gasbarrini A; Cuoco L; Cianei R; Armuzzi A; Fedeli P; Fedeli G; Gasbarrini G Aliment Pharmacol Ther; 1998 Jun; 12(6):539-43. PubMed ID: 9678813 [TBL] [Abstract][Full Text] [Related]
16. Ranitidine bismuth citrate plus clarithromycin 7-day regimen is effective in eradicating Helicobacter pylori in patients with duodenal ulcer. Pozzato P; Zagari M; Cardelli A; Catalano FA; Giglio A; Lami F; Pilotto A; Scarpulla G; Spadaccini A; Susi D; Tosatto R; Olivieri A; Bazzoli F; Roda E Aliment Pharmacol Ther; 1998 May; 12(5):447-51. PubMed ID: 9663724 [TBL] [Abstract][Full Text] [Related]
17. Optimal treatment of Helicobacter pylori with ranitidine bismuth citrate (RBC): a randomized comparison between two 7-day triple therapies and a 14-day dual therapy. de Boer WA; Haeck PW; Otten MH; Mulder CJ Am J Gastroenterol; 1998 Jul; 93(7):1101-7. PubMed ID: 9672338 [TBL] [Abstract][Full Text] [Related]
18. Lansoprazole-based triple therapy versus ranitidine bismuth citrate-based dual therapy in the eradication of Helicobacter pylori in patients with duodenal ulcer: a multicenter, randomized, double-dummy study. Luzza F; Giglio A; Ciliberto E; Belmonte A; Cavaliere C; Saccà N; Frandina C; Fiocca R; Trimboli V; Pallone F Clin Ther; 2001 May; 23(5):761-70. PubMed ID: 11394734 [TBL] [Abstract][Full Text] [Related]
19. Ranitidine bismuth citrate plus clarithromycin: a dual therapy regimen for patients with duodenal ulcer. Lanza FL; Sontag SJ; Ciociola AA; Sykes DL; Heath A; McSorley DJ Helicobacter; 1998 Sep; 3(3):212-21. PubMed ID: 9731994 [TBL] [Abstract][Full Text] [Related]
20. Five-day regimens containing ranitidine bismuth citrate plus high-dose clarithromycin and either amoxycillin or tinidazole for Helicobacter pylori infection. Cammarota G; Cannizzaro O; Ojetti V; Cianci R; Pastorelli A; Armuzzi A; Gentiloni N; Gasbarrini A; Pirozzi G; Gasbarrini G Aliment Pharmacol Ther; 2000 Jan; 14(1):73-7. PubMed ID: 10632648 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]